Federal Executive Boards

EQS-News: Medios AG: achieves further growth in the first half of 2023 and expects strong third quarter

Retrieved on: 
Monday, August 14, 2023

Berlin, August 14, 2023 – Medios AG ("Medios"), the leading provider of Specialty Pharma Solutions in Germany, has continued its growth course in the first half of 2023 and expects a strong third quarter.

Key Points: 
  • Berlin, August 14, 2023 – Medios AG ("Medios"), the leading provider of Specialty Pharma Solutions in Germany, has continued its growth course in the first half of 2023 and expects a strong third quarter.
  • Matthias Gaertner, CEO of Medios AG: "The first half of the year was again successful for Medios.
  • We were able to continue implementing our growth strategy as planned and are ideally positioned for a strong second half of 2023.
  • The revenue growth of the Medios Group in the first half of 2023 was attributable to continued organic growth in both operating segments.

EQS-News: adesso SE increases sales by 33 % in first six months of 2023 to new half-year record of EUR 546.3 million / EBITDA contribution in second quarter lower as expected / full-year forecast confirmed

Retrieved on: 
Monday, August 14, 2023

Driven by consistently high demand for adesso’s IT services across all industries, sales revenues rose to a new half-year record of EUR 546.3 million.

Key Points: 
  • Driven by consistently high demand for adesso’s IT services across all industries, sales revenues rose to a new half-year record of EUR 546.3 million.
  • EBITDA declined by 34 % year on year to EUR 25.2 million, of which EUR 7.2 million is attributable to the second quarter of 2023.
  • As in the previous financial year, a significant earnings contribution is anticipated in the second six months.
  • After having already achieved first place among IT employers in 2016, 2018 and 2020, adesso was ranked first again in 2023

EQS-News: VARTA AG: VARTA AG looks to the future with growing confidence

Retrieved on: 
Friday, August 11, 2023

Restructuring is making progress: The cost reductions in all areas as well as the working capital optimisations are running successfully.

Key Points: 
  • Restructuring is making progress: The cost reductions in all areas as well as the working capital optimisations are running successfully.
  • Increase in business expected in the second half of 2023 due to seasonal factors and customer projects starting up.
  • However, the persistently challenging macroeconomic situation has continued to have a negative impact on manufacturing companies such as VARTA AG in recent months.
  • VARTA AG is optimistic about the coming months despite the continuing challenging overall economic situation.

EQS-News: Bechtle Confirms Forecast after Successful Q2

Retrieved on: 
Friday, August 11, 2023

Neckarsulm, 11 August 2023 – Bechtle AG continued to move forward on its successful growth path in the second quarter of the 2023 fiscal year.

Key Points: 
  • Neckarsulm, 11 August 2023 – Bechtle AG continued to move forward on its successful growth path in the second quarter of the 2023 fiscal year.
  • As of 30 June 2023, Bechtle had 14,505 employees, 1,306 more than in the prior year.
  • The good performance at group level was again driven by the IT System House & Managed Services segment.
  • “Of course, we at Bechtle notice the difficult framework conditions and the associated uncertainties.

EQS-News: Epigenomics AG publishes financial results for the first six months 2023

Retrieved on: 
Thursday, August 10, 2023

Berlin (Germany), August 10, 2023 - Epigenomics AG (FSE: ECX, the "Company") today reported financial results (IFRS, unaudited) for the second quarter and first half of 2023.

Key Points: 
  • Berlin (Germany), August 10, 2023 - Epigenomics AG (FSE: ECX, the "Company") today reported financial results (IFRS, unaudited) for the second quarter and first half of 2023.
  • Ultimately, an agreement was reached with New Day Diagnostics LLC on July 24, 2023, to sell substantially all of Epigenomics' assets.
  • In terms of cash consumption, Epigenomics forecasts a range of EUR 7.0 million to EUR 9.0 million for the current full year 2023.
  • The interim statement for the first half of 2023 (unaudited) can be found on Epigenomics' website at: https://www.epigenomics.com/news-investors/financial-reports/ .

EQS-News: STEMMER IMAGING successful in its strategic transformation and on track for 2023 earnings forecast: Significant revenue and earnings growth in H1, gross margin at all-time high

Retrieved on: 
Thursday, August 10, 2023

In the first half of 2023, STEMMER IMAGING increased revenue by 8.3% year-on-year to EUR 78.4 million (H1 2022: EUR 72.4 million).

Key Points: 
  • In the first half of 2023, STEMMER IMAGING increased revenue by 8.3% year-on-year to EUR 78.4 million (H1 2022: EUR 72.4 million).
  • Revenue in the second quarter increased by 4.1% to EUR 38.0 million (Q2 2022: EUR 36.5 million).
  • From a regional perspective, particularly the Spanish subgroup Infaimon and the local company in the United Kingdom contributed to the revenue growth.
  • In the second quarter, STEMMER IMAGING also achieved an all-time-high quarterly margin of 40.0% (Q2 2022: 37.4%), underlining the positive strategic development.

EQS-News: R. STAHL significantly improves sales and profitability in the first half of 2023

Retrieved on: 
Wednesday, August 9, 2023

Waldenburg, 9 August 2023 - R. STAHL closed out the first half of 2023 very successfully.

Key Points: 
  • Waldenburg, 9 August 2023 - R. STAHL closed out the first half of 2023 very successfully.
  • Demand for the company’s products and services was very high in nearly all regions and industries once again in the second quarter of 2023.
  • For 2023, R. STAHL expects a further recovery in the relevant key markets based on the overall economic and industry-specific forecasts.
  • In terms of free cash flow, R. STAHL forecasted a low single-digit positive million euro amount in April 2023.

EQS-News: Exasol publishes preliminary figures for the first half of 2023, outlook confirmed

Retrieved on: 
Tuesday, August 8, 2023

Exasol publishes preliminary figures for the first half of 2023, outlook confirmed

Key Points: 
  • Exasol publishes preliminary figures for the first half of 2023, outlook confirmed
    The issuer is solely responsible for the content of this announcement.
  • Exasol publishes preliminary figures for the first half of 2023, outlook confirmed
    - Cash and cash equivalents at EUR 11.7 million as of June 30, 2023
    Nuremberg, 8.
  • "Several major customer projects that we expected to close in the first half of the year were postponed to the second half.
  • As a result, overall revenue development in the first half of the year fell short of our expectations," explains Jörg Tewes, CEO of Exasol AG.

NATURAL GAS, LNG AND HYDROGEN IN FOCUS AT GASTECH LEADERSHIP ROUNDTABLES

Retrieved on: 
Wednesday, August 2, 2023

This will be in sharp focus at the Leadership Roundtables being held in Singapore at Gastech, a world-leading energy conference, from 5-8 September 2023.

Key Points: 
  • This will be in sharp focus at the Leadership Roundtables being held in Singapore at Gastech, a world-leading energy conference, from 5-8 September 2023.
  • Each closed-door session will welcome up to 30 high-level participants including the energy sector's most distinguished thought leaders, strategists, policymakers, analysts, and commentators.
  • A range of measures are already being evaluated, from responsibly produced gas to CCUS to more efficient engines in ships.
  • Convening a broad panel of public and private sector players will ensure that these important questions are not just asked but answered.

EQS-News: Krones AG: Krones with successful first half-year 2023

Retrieved on: 
Tuesday, August 1, 2023

Krones has raised its guidance for revenue growth in the full year 2023.

Key Points: 
  • Krones has raised its guidance for revenue growth in the full year 2023.
  • Krones therefore expects order intake to continue developing well at a normalised level in the second half of 2023.
  • As a result of the continued strong demand, Krones’ order backlog further increased despite the higher output in the first half of 2023.
  • In the second quarter of 2023, Krones’ EBITDA increased by 20.9 % year on year to €106.5 million.